These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28064372)

  • 41. Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease.
    Elsaid MI; Li Y; Bridges JFP; Brock G; Minacapelli CD; Rustgi VK
    JAMA Netw Open; 2022 Oct; 5(10):e2235003. PubMed ID: 36205997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minimally Invasive Sleeve Gastrectomy as a Surgical Treatment for Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients.
    Ayloo S; Guss C; Pentakota SR; Hanna J; Molinari M
    Transplant Proc; 2020; 52(1):276-283. PubMed ID: 31889539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.
    Nobili V; Vajro P; Dezsofi A; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):550-61. PubMed ID: 25591123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study.
    Pooler BD; Wiens CN; McMillan A; Artz NS; Schlein A; Covarrubias Y; Hooker J; Schwimmer JB; Funk LM; Campos GM; Greenberg JA; Jacobsen G; Horgan S; Wolfson T; Gamst AC; Sirlin CB; Reeder SB
    Radiology; 2019 Mar; 290(3):682-690. PubMed ID: 30561273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional Liver Recovery After Bariatric Surgery--a Prospective Cohort Study with the LiMAx Test.
    Alizai PH; Wendl J; Roeth AA; Klink CD; Luedde T; Steinhoff I; Neumann UP; Schmeding M; Ulmer F
    Obes Surg; 2015 Nov; 25(11):2047-53. PubMed ID: 25869925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
    Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C).
    Mamidipalli A; Fowler KJ; Hamilton G; Wolfson T; Covarrubias Y; Tran C; Fazeli S; Wiens CN; McMillan A; Artz NS; Funk LM; Campos GM; Greenberg JA; Gamst A; Middleton MS; Schwimmer JB; Reeder SB; Sirlin CB
    Eur Radiol; 2020 Sep; 30(9):5120-5129. PubMed ID: 32318847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60.
    Abbas M; Cumella L; Zhang Y; Choi J; Vemulapalli P; Melvin WS; Camacho D
    Obes Surg; 2015 Dec; 25(12):2251-6. PubMed ID: 26001882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand Setting.
    Collins H; Beban G; Windsor J; Ram R; Orr D; Evennett N; Loveday B
    Obes Surg; 2020 Jan; 30(1):313-318. PubMed ID: 31482482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Clinical Value and Appropriateness Criteria of Upper Abdominal Magnetic Resonance Examinations in Patients Before and After Bariatric Surgery: a Study of 837 Images.
    Lv H; Li M; Liu Y; Zhao L; Sun J; Cao D; Zeng N; Liu J; Liu Y; Bian S; Zhang P; Yang Z; Zhang Z; Wang Z
    Obes Surg; 2020 Oct; 30(10):3784-3791. PubMed ID: 32483745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients.
    Billeter AT; Senft J; Gotthardt D; Knefeli P; Nickel F; Schulte T; Fischer L; Nawroth PP; Büchler MW; Müller-Stich BP
    Obes Surg; 2016 Aug; 26(8):1867-74. PubMed ID: 26660688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
    Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
    Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between abdominal fat stores and liver fat, pancreatic fat, and metabolic comorbidities in a pediatric population with non-alcoholic fatty liver disease.
    Trout AT; Hunte DE; Mouzaki M; Xanthakos SA; Su W; Zhang B; Dillman JR
    Abdom Radiol (NY); 2019 Sep; 44(9):3107-3114. PubMed ID: 31312893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery.
    Jiménez-Agüero R; Emparanza JI; Beguiristain A; Bujanda L; Alustiza JM; García E; Hijona E; Gallego L; Sánchez-González J; Perugorria MJ; Asensio JI; Larburu S; Garmendia M; Larzabal M; Portillo MP; Aguirre L; Banales JM
    BMC Med; 2014 Aug; 12():137. PubMed ID: 25164060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery.
    Allen AM; Shah VH; Therneau TM; Venkatesh SK; Mounajjed T; Larson JJ; Mara KC; Schulte PJ; Kellogg TA; Kendrick ML; McKenzie TJ; Greiner SM; Li J; Glaser KJ; Wells ML; Chen J; Ehman RL; Yin M
    Hepatology; 2020 Feb; 71(2):510-521. PubMed ID: 30582669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding.
    Folini L; Veronelli A; Benetti A; Pozzato C; Cappelletti M; Masci E; Micheletto G; Pontiroli AE
    Acta Diabetol; 2014; 51(3):361-8. PubMed ID: 24085682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How best to combine liver transplantation and bariatric surgery?-Results from a global, web-based survey.
    Widmer J; Eden J; Abbassi F; Angelico R; Rössler F; Müllhaupt B; Dutkowski P; Bueter M; Schlegel A
    Liver Int; 2024 Feb; 44(2):566-576. PubMed ID: 38082500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
    Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
    Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic review of bariatric surgery liver biopsies clarifies the natural history of liver disease in patients with severe obesity.
    Bedossa P; Tordjman J; Aron-Wisnewsky J; Poitou C; Oppert JM; Torcivia A; Bouillot JL; Paradis V; Ratziu V; Clément K
    Gut; 2017 Sep; 66(9):1688-1696. PubMed ID: 27884920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.